American Healthcare REIT (AHR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $53.23, +0.42% vs the prior close of $53.01.
- Volume 2.34M shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AHR rises 0.4% to $53.23, a 1-month high. Closed at $53.23, +0.42% vs the prior close of $53.01. Day range $52.60–$53.52, opened at $53.39.
AHR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AHR rises 0.4% to $53.23, a 1-month high
- Closed at $53.23, +0.42% vs the prior close of $53.01. Day range $52.60–$53.52, opened at $53.39.
- Volume was 2.34M shares, 0.7x its 50-day average of 3.16M.
- Price is -0.5% vs its 50-day average ($53.50) and +4.0% vs its 200-day average ($51.19).
- 52-week range $41.67–$58.70; today's close sits at 68% of that range, 9.3% below the 52-week high.
Oct 15, 2026 — AHR rises 1.1% to $53.01
- Closed at $53.01, +1.13% vs the prior close of $52.42. Day range $52.64–$53.35, opened at $53.35.
- Volume was 3.71M shares, 1.2x its 50-day average of 3.13M.
- Price is -1.0% vs its 50-day average ($53.53) and +3.6% vs its 200-day average ($51.16).
- 52-week range $41.38–$58.70; today's close sits at 67% of that range, 9.7% below the 52-week high.
Oct 14, 2026 — AHR ends flat (-0.2%) to $52.42
- Closed at $52.42, -0.21% vs the prior close of $52.53. Day range $51.91–$53.14, opened at $52.80.
- Volume was 2.22M shares, 0.7x its 50-day average of 3.14M.
- Price is -2.2% vs its 50-day average ($53.58) and +2.5% vs its 200-day average ($51.14).
- 52-week range $41.15–$58.70; today's close sits at 64% of that range, 10.7% below the 52-week high.
Oct 13, 2026 — AHR ends flat (+0.0%) to $52.53, 4 up days in a row
- Closed at $52.53, +0.02% vs the prior close of $52.52. Day range $52.26–$53.29, opened at $53.29.
- Volume was 2.90M shares, 0.9x its 50-day average of 3.11M.
- Price is -2.0% vs its 50-day average ($53.62) and +2.8% vs its 200-day average ($51.12).
- 52-week range $40.30–$58.70; today's close sits at 66% of that range, 10.5% below the 52-week high.
- That makes 4 straight gains.
Oct 12, 2026 — AHR jumps 3.4% to $52.52, 3 up days in a row
- Closed at $52.52, +3.39% vs the prior close of $50.80. Day range $50.60–$52.54, opened at $51.02.
- Volume was 2.44M shares, 0.8x its 50-day average of 3.09M.
- Price is -2.2% vs its 50-day average ($53.68) and +2.8% vs its 200-day average ($51.10).
- 52-week range $40.20–$58.70; today's close sits at 67% of that range, 10.5% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — AHR rises 0.7% to $50.80
- Closed at $50.80, +0.71% vs the prior close of $50.44. Day range $50.26–$51.08, opened at $50.69.
- Volume was 1.71M shares, 0.6x its 50-day average of 3.10M — lighter than usual.
- Price is -5.5% vs its 50-day average ($53.74) and -0.5% vs its 200-day average ($51.08).
- 52-week range $40.00–$58.70; today's close sits at 58% of that range, 13.5% below the 52-week high.
Oct 8, 2026 — AHR rises 2.2% to $50.44
- Closed at $50.44, +2.17% vs the prior close of $49.37. Day range $49.25–$50.94, opened at $49.52.
- Volume was 3.38M shares, 1.1x its 50-day average of 3.09M.
- Price is -6.3% vs its 50-day average ($53.84) and -1.2% vs its 200-day average ($51.06).
- 52-week range $40.00–$58.70; today's close sits at 56% of that range, 14.1% below the 52-week high.
Oct 7, 2026 — AHR dips 2.2% to $49.37, a 3-month low
- Closed at $49.37, -2.22% vs the prior close of $50.49. Day range $49.31–$50.81, opened at $50.49.
- Volume was 4.15M shares, 1.4x its 50-day average of 3.06M.
- Price is -8.5% vs its 50-day average ($53.98) and -3.3% vs its 200-day average ($51.05).
- 52-week range $40.00–$58.70; today's close sits at 50% of that range, 15.9% below the 52-week high.
Oct 6, 2026 — AHR ends flat (+0.0%) to $50.49
- Closed at $50.49, +0.04% vs the prior close of $50.47. Day range $50.02–$50.85, opened at $50.60.
- Volume was 3.78M shares, 1.2x its 50-day average of 3.03M.
- Price is -6.7% vs its 50-day average ($54.14) and -1.1% vs its 200-day average ($51.04).
- 52-week range $40.00–$58.70; today's close sits at 56% of that range, 14.0% below the 52-week high.
Oct 5, 2026 — AHR dips 0.6% to $50.47, a 3-month low
- Closed at $50.47, -0.55% vs the prior close of $50.75. Day range $50.27–$51.22, opened at $50.33.
- Volume was 4.05M shares, 1.4x its 50-day average of 2.99M.
- Price is -7.0% vs its 50-day average ($54.28) and -1.1% vs its 200-day average ($51.03).
- 52-week range $40.00–$58.70; today's close sits at 56% of that range, 14.0% below the 52-week high.
Oct 2, 2026 — AHR ends flat (+0.1%) to $50.75
- Closed at $50.75, +0.12% vs the prior close of $50.69. Day range $50.57–$51.70, opened at $50.92.
- Volume was 2.44M shares, 0.8x its 50-day average of 2.99M.
- Price is -6.7% vs its 50-day average ($54.42) and -0.5% vs its 200-day average ($51.02).
- 52-week range $40.00–$58.70; today's close sits at 57% of that range, 13.5% below the 52-week high.
AHR latest news & SEC filings
Every SEC filing by or about AHR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Foster Mark E. sold 1,500 shares at $52.06 (≈$78.09K) on Sep 25, 2026; now holds 50,117
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Foster Mark E. sold 2,000 shares at $55.39 (≈$110.78K) on Sep 1, 2026
- Foster Mark E. sold 2,000 shares at $55.39 (≈$110.78K) on Sep 1, 2026
- Foster Mark E. sold 2,000 shares at $55.39 (≈$110.78K) on Sep 1, 2026
- Foster Mark E. sold 2,000 shares at $55.39 (≈$110.78K) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 11, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 10, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $634.52M (prior year $501.29M) (+26.6% vs Jun 30, 2025)
- Net income: $30.61M (prior year $9.91M) (+208.9% vs Jun 30, 2025)
- Diluted EPS: $0.16 (prior year $0.06) (+166.7% vs Jun 30, 2025)
Things to know before you trade AHR
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.87% (largest 3.4%). That is a relatively calm stock.
- Liquidity: about 2.92M shares (≈$155.22M) trade per day on average.
- 52-week position: $53.23 vs a range of $41.67–$58.70 (68% of the range).
- Dividends: last ex-dividend date Sep 30, 2026 ($0.25/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Mark E. Foster sold 1,500 shares on Sep 25, 2026.
- Latest filings: 8-K Sep 18, 2026; 8-K Sep 14, 2026; 8-K Sep 2, 2026.
- Share count: 218.00M shares outstanding (Aug 3, 2026), +29.3% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Real Estate Investment Trusts.
AHR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 53.39 | 53.52 | 52.60 | 53.23 | 2.34M |
| Oct 15, 2026 | 53.35 | 53.35 | 52.64 | 53.01 | 3.71M |
| Oct 14, 2026 | 52.80 | 53.14 | 51.91 | 52.42 | 2.22M |
| Oct 13, 2026 | 53.29 | 53.29 | 52.26 | 52.53 | 2.90M |
| Oct 12, 2026 | 51.02 | 52.54 | 50.60 | 52.52 | 2.44M |
| Oct 9, 2026 | 50.69 | 51.08 | 50.26 | 50.80 | 1.71M |
| Oct 8, 2026 | 49.52 | 50.94 | 49.25 | 50.44 | 3.38M |
| Oct 7, 2026 | 50.49 | 50.81 | 49.31 | 49.37 | 4.15M |
| Oct 6, 2026 | 50.60 | 50.85 | 50.02 | 50.49 | 3.78M |
| Oct 5, 2026 | 50.33 | 51.22 | 50.27 | 50.47 | 4.05M |
| Oct 2, 2026 | 50.92 | 51.70 | 50.57 | 50.75 | 2.44M |
| Oct 1, 2026 | 51.44 | 51.44 | 50.36 | 50.69 | 2.88M |
| Sep 30, 2026 | 51.80 | 51.80 | 51.21 | 51.26 | 3.15M |
| Sep 29, 2026 | 52.02 | 52.45 | 51.62 | 52.08 | 2.62M |
| Sep 28, 2026 | 52.04 | 52.47 | 51.64 | 51.90 | 2.05M |
| Sep 25, 2026 | 52.30 | 52.48 | 51.90 | 52.02 | 2.72M |
| Sep 24, 2026 | 52.09 | 52.84 | 51.83 | 52.31 | 2.46M |
| Sep 23, 2026 | 51.51 | 52.30 | 51.31 | 51.70 | 3.87M |
| Sep 22, 2026 | 52.25 | 52.33 | 51.61 | 51.69 | 2.77M |
| Sep 21, 2026 | 53.15 | 53.15 | 52.11 | 52.30 | 2.66M |
About American Healthcare REIT
American Healthcare REIT (AHR) is listed on the NYSE and classified by the SEC under “Real Estate Investment Trusts”. Its business address is in IRVINE, CA. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1632970.
AHR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Scott A Estes | Director | Jun 26, 2026 |
| Brian J. Flornes | Director | Jun 26, 2026 |
| Jeffrey T Hanson | Chief Executive Officer | Jul 22, 2026 |
| Dianne Hurley | Director | Jun 26, 2026 |
| Marvin R O'Quinn | Director | Jun 26, 2026 |
| Danny Prosky | Director | Aug 4, 2026 |
| Valerie Richardson | Director | Jun 26, 2026 |
| Wilbur H Iii Smith | Director | Jun 26, 2026 |
| Mathieu B. Streiff | Director | Jun 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark E. Foster | EVP, GC & Secretary | Sep 28, 2026 |
| Jeffrey T Hanson | Chief Executive Officer | Jul 22, 2026 |
| Stefan K.L. Oh | Chief Investment Officer | Apr 8, 2026 |
| Brian Peay | Chief Financial Officer | Jun 29, 2026 |
| Gabriel M Willhite | President & COO | Jul 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Mark E. Foster | Sale | 1,500 | $52.06 |
| Sep 25, 2026 | Mark E. Foster | Sale | 1,500 | $52.06 |
| Sep 25, 2026 | Mark E. Foster | Sale | 1,500 | $52.06 |
| Sep 25, 2026 | Mark E. Foster | Sale | 1,500 | $52.06 |
| Sep 1, 2026 | Mark E. Foster | Sale | 2,000 | $55.39 |
| Sep 1, 2026 | Mark E. Foster | Sale | 2,000 | $55.39 |
| Sep 1, 2026 | Mark E. Foster | Sale | 2,000 | $55.39 |
| Sep 1, 2026 | Mark E. Foster | Sale | 2,000 | $55.39 |
| Jun 26, 2026 | Brian Peay | Sale | 25,000 | $50.70 |
| Jun 26, 2026 | Brian Peay | Sale | 25,000 | $50.70 |
| Jun 26, 2026 | Brian Peay | Sale | 25,000 | $50.70 |
| Jun 26, 2026 | Brian Peay | Sale | 25,000 | $50.70 |
| Jun 24, 2026 | Mark E. Foster | Sale | 2,500 | $48.58 |
| Jun 24, 2026 | Mark E. Foster | Sale | 2,500 | $48.58 |
| Jun 24, 2026 | Mark E. Foster | Sale | 2,500 | $48.58 |
AHR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.09B | $69.81M | 0.42 | $294.44M |
| Dec 31, 2024 | $1.88B | $-37.81M | -0.29 | $176.09M |
| Dec 31, 2023 | $1.67B | $-71.47M | -1.08 | $98.53M |
| Dec 31, 2022 | $1.41B | $-81.30M | -1.24 | $147.77M |
| Dec 31, 2021 | $1.12B | $-47.79M | -0.95 | $17.91M |
Latest balance sheet: total assets $5.70B, total liabilities $1.96B, cash $156.90M (as of Jun 30, 2026).
AHR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $54.71 |
| May 7, 2026 | 8-K Item 2.02 (results) | $49.60 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $53.19 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $47.92 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $39.86 |
| May 8, 2025 | 8-K Item 2.02 (results) | $32.21 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $25.91 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 21, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Real Estate Investment Trusts
Welltower (WELL)American Tower (AMT)Prologis (PLD)Realty Income (O)Equinix (EQIX)Crown Castle (CCI)Ventas (VTR)AGNC Investment (AGNC)Digital Realty (DLR)Vivmark Residential (VMRK)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AHR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.